Tumor suppressor miRNA-509-5p suppresses the expression of immortality gene telomerase via down regulation of its target gene, 31/August/2014, 5.28 am

Therapeutic insights into the treatment of DM: Tumor suppressor ARF suppresses the expression of an activator of insulin transcription, NeuroD1 via up regulation of its target gene 31/August/2014, 5.23 am
August 30, 2014
MiRNA-based Regenerative therapy for T2D: MiRNA-380-5p promotes reprogramming of adult pancreatic ductal cells into α, δ, and β cells via up regulation of Ngn3, 31/August/2014, 5.43 am
August 31, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based cancer stem cell therapeutics: Tumor suppressor miRNA-509-5p  suppresses the expression of immortality gene telomerase via down regulation of its target gene, 31/August/2014, 5.28 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org.

Significance: This study suggests that  miRNA-509-5p, by decreasing the expression of its target gene, it may inhibit telomerase activity.    Furthermore, this study suggests that pharmacological formulations encompassing miRNA-509-5p may aid in the treatment of cancer.

* Research cooperation

Comments are closed.